Bruland ØS - Search Results

1

TP-3 immunotoxins improve antitumor activity in mice with osteosarcoma.

Onda M, Bruland ØS, Pastan I. Onda M, et al. Among authors: bruland os. Clin Orthop Relat Res. 2005 Jan;(430):142-8. doi: 10.1097/01.blo.0000137544.30200.b6. Clin Orthop Relat Res. 2005. PMID: 15662316

2

Cytotoxicity of antiosteosarcoma recombinant immunotoxins composed of TP-3 Fv fragments and a truncated Pseudomonas exotoxin A.

Onda M, Olafsen T, Tsutsumi Y, Bruland OS, Pastan I. Onda M, et al. Among authors: bruland os. J Immunother. 2001 Mar-Apr;24(2):144-50. J Immunother. 2001. PMID: 11265772

3

Cloning and sequencing of V genes from anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: location of lysine residues and implications for radiolabeling.

Olafsen T, Bruland OS, Zalutsky MR, Sandlie I. Olafsen T, et al. Among authors: bruland os. Nucl Med Biol. 1995 Aug;22(6):765-71. doi: 10.1016/0969-8051(95)00014-o. Nucl Med Biol. 1995. PMID: 8535337

4

Abundant tyrosine residues in the antigen binding site in anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: Application to radiolabeling.

Olafsen T, Bruland OS, Zalutsky MR, Sandlie I. Olafsen T, et al. Among authors: bruland os. Acta Oncol. 1996;35(3):297-301. doi: 10.3109/02841869609101644. Acta Oncol. 1996. PMID: 8679259

5

Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodies.

Olafsen T, Munthe Lund CK, Bruland OS, Sandlie I, Michaelsen TE. Olafsen T, et al. Among authors: bruland os. Cancer Immunol Immunother. 1999 Oct;48(7):411-8. doi: 10.1007/s002620050594. Cancer Immunol Immunother. 1999. PMID: 10501855 Free PMC article.

6

Human osteosarcoma xenografts and their sensitivity to chemotherapy.

Bruheim S, Bruland OS, Breistol K, Maelandsmo GM, Fodstad O. Bruheim S, et al. Among authors: bruland os. Pathol Oncol Res. 2004;10(3):133-41. doi: 10.1007/BF03033741. Epub 2004 Sep 25. Pathol Oncol Res. 2004. PMID: 15448748 Free article.

7

Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma.

Westrøm S, Bønsdorff TB, Abbas N, Bruland ØS, Jonasdottir TJ, Mælandsmo GM, Larsen RH. Westrøm S, et al. Among authors: bruland os. PLoS One. 2016 Oct 24;11(10):e0165382. doi: 10.1371/journal.pone.0165382. eCollection 2016. PLoS One. 2016. PMID: 27776176 Free PMC article.

8

Hematogenous micrometastases in osteosarcoma patients.

Bruland OS, Høifødt H, Saeter G, Smeland S, Fodstad O. Bruland OS, et al. Clin Cancer Res. 2005 Jul 1;11(13):4666-73. doi: 10.1158/1078-0432.CCR-05-0165. Clin Cancer Res. 2005. PMID: 16000559

9

Primary osteosarcoma of the breast.

Brustugun OT, Reed W, Poulsen JP, Bruland OS. Brustugun OT, et al. Among authors: bruland os. Acta Oncol. 2005;44(7):767-70. doi: 10.1080/02841860500254897. Acta Oncol. 2005. PMID: 16227171 No abstract available.

10

Inactivation of human osteosarcoma cells in vitro by 211At-TP-3 monoclonal antibody: comparison with astatine-211-labeled bovine serum albumin, free astatine-211 and external-beam X rays.

Larsen RH, Bruland OS, Hoff P, Alstad J, Lindmo T, Rofstad EK. Larsen RH, et al. Among authors: bruland os. Radiat Res. 1994 Aug;139(2):178-84. Radiat Res. 1994. PMID: 8052693

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

228 results

Search Page